What did Boston Scientific Corporation pay for Vertiflex?

Boston Scientific Corporation acquired Vertiflex for $465.0M in 2019, equivalent to 7.80x revenue. Target revenue was approximately $60.0M.

What does Vertiflex do?

Vertiflex is a medical devices business.

What multiple did Boston Scientific Corporation pay for Vertiflex?

7.80x revenue, based on disclosed deal value of $465.0M and disclosed financials.

M&A TRANSACTION · 2019

Vertiflex acquired by Boston Scientific Corporation

$465.0M· 7.80x revenue

Target

Vertiflex

Acquirer

Boston Scientific Corporation

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$60.0M

EBITDA

—

Deal Value

$465.0M

EV/EBITDA

—

Context

This $465.0M acquisition of Vertiflex by Boston Scientific Corporation sits in the medical devices sub-vertical. Boston Scientific Corporation is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.

Source

Data sourced from SEC filings and press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Vertiflex acquisition.

Citation: ExitValue.ai. (2019). Vertiflex acquired by Boston Scientific Corporation. https://exitvalue.ai/deals/vertiflex-acquired-by-boston-scientific-corporation-hc-2019-0147